PATHO financials
A multi-period view of the public annual-account figures reported for PATHO, with comparable measures and links to available source documents.
Company overviewRegistry number
0722570816
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for PATHO
2025 versus 2024
- Operating line
- €64,758
- EBITDA
- -€7,098
- Total assets
- €53,837
- Equity
- €10,854
-36.1%
-203.5%
-19.8%
-48%
EBITDA margin -11% · Equity ratio +20.2%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €64,758 | -€7,098 | €53,837 | €10,854 | - |
| 202431 Dec 2024 | €101,269 | €6,861 | €67,108 | €20,878 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.